Raynovent
Latest round
- Series C
Last raised
- Dec 2022
Total raised
- $117M
Investors
- 11
About Raynovent
, dba Raynovent, is a biotechnology company engaged in developing and commercializing innovative drug pipelines for respiratory and metabolic diseases. The company was formed by and operates as a subsidiary of Zhongsheng Pharma, a pharmaceutical company listed on Shenzhen Stock Exchange. Raynovent's founder, Chaofeng Long, holds a master's degree of Clinical Pharmacology from Beijing Medical University.26 million. Raynovent focuses on the research and development of innovative drug for the treatment of respiratory and metabolic diseases such as Influenza, Primary Biliary Cholangitis (PBC), Nonalcoholic steatohepatitis (NASH) and Avian Influenza. The company generates revenue from developing innovative drugs for respiratory and metabolic diseases.
Who invested in Raynovent
11 investors across 4 rounds
See all investors in Raynovent
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Raynovent
Who invested in Raynovent?
Raynovent has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Raynovent raised?
Raynovent has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Raynovent last raise money?
Raynovent's most recent round on record is a Series C, in Dec 2022.
What does Raynovent do?
, dba Raynovent, is a biotechnology company engaged in developing and commercializing innovative drug pipelines for respiratory and metabolic diseases.
Where is Raynovent headquartered?
Raynovent is headquartered in Guangzhou, China.
Which VCs invest in companies like Raynovent?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Raynovent's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Raynovent? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.